[1]
J. Qian, Y. Xu, X. Ling, and F. Wang, “Overview on Current Trends and Emerging Therapies in the Chemotherapy of Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Trends and Emerging Therapies in Chemotherapy of HER2-positive BC”, Galen Med J, vol. 12, p. e3021, Aug. 2023.